NEW ECONOMY INNOVATION SYSTEMS: BIOTECHNOLOGY IN EUROPE AND THE USA

By Philip Cooke. 2001

134 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Management of Technology and Innovation, Strategy and Management

View Paper: https://www.semanticscholar.org/paper/7958bf8161c5391eaf262fd2568d2577b239dfa6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Management of Technology and Innovation

In Strategy and Management

Citations in the corpus

Contrasting Entrepreneurial Economic Development in Emerging Latin American Economies: Applications and Extensions of Resource-Based Theory (2007, background): “…conducted in more developed regions such as the United States (West & Bamford, 2005) and Western Europe (e.g., Busenitz, Gomez, & Spencer, 2000; Cooke, 2001; Davidsson, 1995), or with respect to technology firms and cluster development (e.g., Cooke & Leydesdorff, 2006; Laukkanen, 2000), where…”
Nodes, networks and proximities: on the knowledge dynamics of the Medicon Valley biotech cluster (2004, background): “For example in the field of monoclonal antibodies, which is presently seen as one of the major biotech growth areas (Cooke, 2001), new antigens (e.g. cell structures carrying harmful viruses or other diseases) are often discovered by researchers at PROs and subsequently acquired by DBFs.”
Venture capital start-up co-evolution and the emergence & development of Israel's new high tech cluster (2004, background): “Venture Capital has been characterized as a ‘private’ business enterprise support mechanism ( Cooke, 2001 ).Venture capitalists invest in new unproven, entrepreneurial enterprises ignored by traditional financial institutions; and due to the problems mentioned above, for many SU companies, VC are th”
What drives patent performance of German biotech firms? The impact of R&D subsidies, knowledge networks and their location (2011, background): “Cooke (2001) argues that Germany lags 20 years behind the USA in respect to the commercialization of the biotechnology industry and 10 years behind the UK.”
Entrepreneurial Geographies: Support Networks in Three High-Technology Industries (2005, background): “…driver of the industrial clustering (see, e.g., Zucker, Darby, and Brewer 1998; Stuart and Sorenson 2003; Romanelli and Feldman 2004). to factors, such as universities, incumbent firms, and venture capital, declined in importance (for a discussion of regions and biotechnology, see Cooke 2001).”
The Digital Economy: what is new and what is not? (2004, unknown): “Another potentially fruitful avenue of research would be to examine the rapidly growing number of studies of innovation systems and industry clusters from a similar standpoint (such as the biotechnology-focused studies of Cooke (2001) and Carlsson (2002)).”
Knowledge context and entrepreneurial intentions among students (2012, background): “2004) and that innovative clusters provide a particularly fertile soil for the formation and growth of firm start-ups (Porter 1998; Cooke 2001; Ketels 2004).”
Local Nodes in Global Networks: The Geography of Knowledge Flows in Biotechnology Innovation (2005, background): “…emerging from prior research on innovativeness and performance in biotechnology, since this key input provides both the investment capital and the entrepreneurial and managerial know-how necessary for commercial success (Zucker et al., 1998b; Niosi, 2000a, b; Cooke, 2001b; Powell et al., 2002).”
Does Biotech Reflect a New Science-based Innovation Regime? (2003, background): “the industry by configuring it into regional clusters (Cooke 2001).”